Seed Therapeutics
Business Services · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
411 Swedeland Rd Ste 1000, King Of Pruss...Phone Number
(646) 305-6387Website
www.seedtherapeutics.comRevenue
$5.3 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Seed Therapeutics
SEED Therapeutics specializes in designing molecular glue degraders that utilize the full E3 ligase universe to target and eliminate disease proteins, particularly in oncology. Their innovative RITE3 platform enables the identification of optimal ligase-target pairs, allowing for a more precise approach to targeted protein degradation. The company is currently advancing its lead product, ST-01156, through Phase 1 trials for various tumors, supported by strategic partnerships with industry leaders like Lilly and Eisai. SEED Therapeutics aims to make a significant impact on patient care by developing therapies for diseases where traditional treatments have failed.Explore more
Seed Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Seed Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Seed Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Seed Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Check if Seed Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Seed Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Seed Therapeutics
Funding: Get notified immidiatlly once Seed Therapeutics has new funding data
Earning: See what the market has to say on Seed Therapeutics recently announced quarterly report
Click to see if Seed Therapeutics had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Seed Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Seed Therapeutics
Compare insights from companies similar to Seed Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Seed Therapeutics
$5.3M
11-50
Private
-
-
William DesmaraisChief Financial Officer & Chief Business Officer
Company Profile Activity
Activity Insights
Seed Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Seed Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Seed Therapeutics.
Seed Therapeutics Tech Stack
A closer look at the technologies used by Seed Therapeutics
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
Executive Moves, New Hire
Executive Move
Board of Directors
Executive Move
Top Business Services Companies
Frequently Asked Questions Regarding Seed Therapeutics
Sign Up For FreeTo access detailed company insights
SEED Therapeutics specializes in designing molecular glue degraders that utilize the full E3 ligase universe to target and eliminate disease proteins, particularly in oncology. Their innovative RITE3 platform enables the identification of optimal ligase-target pairs, allowing for a more precise approach to targeted protein degradation. The company... Read More
